Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases
Publication
, Journal Article
Kurtzberg, J; Buntz, S; Gentry, T; Storms, R; Wenger, DA; Noldner, P; Zhou, J; Ozamiz, A; Rusche, B; Balber, A
Published in: Cytotherapy
April 2014
Duke Scholars
Published In
Cytotherapy
DOI
ISSN
1465-3249
Publication Date
April 2014
Volume
16
Issue
4
Start / End Page
S16 / S17
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3206 Medical biotechnology
- 3204 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kurtzberg, J., Buntz, S., Gentry, T., Storms, R., Wenger, D. A., Noldner, P., … Balber, A. (2014). Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases. Cytotherapy, 16(4), S16–S17. https://doi.org/10.1016/j.jcyt.2014.01.044
Kurtzberg, J., S. Buntz, T. Gentry, R. Storms, D. A. Wenger, P. Noldner, J. Zhou, A. Ozamiz, B. Rusche, and A. Balber. “Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases.” Cytotherapy 16, no. 4 (April 2014): S16–17. https://doi.org/10.1016/j.jcyt.2014.01.044.
Kurtzberg J, Buntz S, Gentry T, Storms R, Wenger DA, Noldner P, et al. Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases. Cytotherapy. 2014 Apr;16(4):S16–7.
Kurtzberg, J., et al. “Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases.” Cytotherapy, vol. 16, no. 4, Elsevier BV, Apr. 2014, pp. S16–17. Crossref, doi:10.1016/j.jcyt.2014.01.044.
Kurtzberg J, Buntz S, Gentry T, Storms R, Wenger DA, Noldner P, Zhou J, Ozamiz A, Rusche B, Balber A. Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases. Cytotherapy. Elsevier BV; 2014 Apr;16(4):S16–S17.
Published In
Cytotherapy
DOI
ISSN
1465-3249
Publication Date
April 2014
Volume
16
Issue
4
Start / End Page
S16 / S17
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3206 Medical biotechnology
- 3204 Immunology
- 1103 Clinical Sciences